|
1
|
Samimi M and Touzé A: Merkel cell
carcinoma: The first human cancer shown to be associated with a
polyomavirus. Presse Med. 43:e405–e411. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jankowski M, Kopinski P, Schwartz R and
Czajkowski R: Merkel cell carcinoma: Is this a true carcinoma? Exp
Dermatol. 23:792–794. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Morrison KM, Miesegaes GR, Lumpkin EA and
Maricich SM: Mammalian Merkel cells are descended from the
epidermal lineage. Dev Biol. 336:76–83. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hausen Zur A, Rennspiess D, Winnepenninckx
V, Speel EJ and Kurz AK: Early B-cell differentiation in Merkel
cell carcinomas: Clues to cellular ancestry. Cancer Res.
73:4982–4987. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bichakjian CK, Lowe L, Lao CD, Sandler HM,
Bradford CR, Johnson TM and Wong SL: Merkel cell carcinoma:
Critical review with guidelines for multidisciplinary management.
Cancer. 110:1–12. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Agelli M and Clegg LX: Epidemiology of
primary Merkel cell carcinoma in the United States. J Am Acad
Dermatol. 49:832–841. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Afanasiev OK, Yelistratova L, Miller N,
Nagase K, Paulson K, Iyer JG, Ibrani D, Koelle DM and Nghiem P:
Merkel polyomavirus-specific T cells fluctuate with merkel cell
carcinoma burden and express therapeutically targetable PD-1 and
Tim-3 exhaustion markers. Clin Cancer Res. 19:5351–5360. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Heath M, Jaimes N, Lemos B, Mostaghimi A,
Wang LC, Peñas PF and Nghiem P: Clinical characteristics of Merkel
cell carcinoma at diagnosis in 195 patients: The AEIOU features. J
Am Acad Dermatol. 58:375–381. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Albores-Saavedra J, Batich K,
Chable-Montero F, Sagy N, Schwartz AM and Henson DE: Merkel cell
carcinoma demographics, morphology, and survival based on 3870
cases: A population based study. J Cutan Pathol. 37:20–27. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Becker JC: Merkel cell carcinoma. Ann
Oncol. 21 Suppl 7:vii81–vii85. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lunder EJ and Stern RS: Merkel-cell
carcinomas in patients treated with methoxsalen and ultraviolet A
radiation. N Engl J Med. 339:1247–1248. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wooff JC, Trites JR, Walsh NM and Bullock
MJ: Complete spontaneous regression of metastatic merkel cell
carcinoma: A case report and review of the literature. Am J
Dermatopathol. 32:614–617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Burack J and Altschuler EL: Sustained
remission of metastatic Merkel cell carcinoma with treatment of HIV
infection. J R Soc Med. 96:238–239. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chang Y and Moore PS: Merkel cell
carcinoma: A virus-induced human cancer. Annu Rev Pathol.
7:123–244. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Feng H, Shuda M, Chang Y and Moore PS:
Clonal integration of a polyomavirus in human Merkel cell
carcinoma. Science. 319:1096–1100. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kuwamoto S: Recent advances in the biology
of Merkel cell carcinoma. Hum Pathol. 42:1063–1077. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Foulongne V, Kluger N, Dereure O, Mercier
G, Molès JP, Guillot B and Segondy M: Merkel cell polyomavirus in
cutaneous swabs. Emerg Infect Dis. 16:685–687. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schowalter RM, Pastrana DV, Pumphrey KA,
Moyer AL and Buck CB: Merkel cell polyomavirus and two previously
unknown polyomaviruses are chronically shed from human skin. Cell
Host Microbe. 7:509–515. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Loyo M, Guerrero-Preston R, Brait M, Hoque
MO, Chuang A, Kim MS, Sharma R, Liégeois NJ, Koch WM, Califano JA,
et al: Quantitative detection of Merkel cell virus in human tissues
and possible mode of transmission. Int J Cancer. 126:2991–2966.
2010.PubMed/NCBI
|
|
20
|
Kantola K, Sadeghi M, Lahtinen A,
Koskenvuo M, Aaltonen LM, Möttönen M, Rahiala J, Saarinen-Pihkala
U, Riikonen P, Jartti T, et al: Merkel cell polyomavirus DNA in
tumor-free tonsillar tissues and upper respiratory tract samples:
Implications for respiratory transmission and latency. J Clin
Virol. 45:292–295. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Babakir-Mina M, Ciccozzi M, Lo Presti A,
Greco F, Perno CF and Ciotti M: Identification of Merkel cell
polyomavirus in the lower respiratory tract of Italian patients. J
Med Virol. 82:505–509. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bialasiewicz S, Lambert SB, Whiley DM,
Nissen MD and Sloots TP: Merkel cell polyomavirus DNA in
respiratory specimens from children and adults. Emerg Infect Dis.
15:492–494. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Goh S, Lindau C, Tiveljung-Lindell A and
Allander T: Merkel cell polyomavirus in respiratory tract
secretions. Emerg Infect Dis. 15:489–491. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bhatia S, Afanasiev O and Nghiem P:
Immunobiology of Merkel cell carcinoma: Implications for
immunotherapy of a polyomavirus-associated cancer. Curr Oncol Rep.
13:488–497. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Spurgeon ME and Lambert PF: Merkel cell
polyomavirus: A newly discovered human virus with oncogenic
potential. Virology. 435:118–130. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shuda M, Feng H, Kwun HJ, Rosen ST,
Gjoerup O, Moore PS and Chang Y: T antigen mutations are a human
tumor-specific signature for Merkel cell polyomavirus. Proc Natl
Acad Sci USA. 105:16272–16277. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shuda M, Chang Y and Moore PS: Merkel cell
polyomavirus positive Merkel cell carcinoma requires viral small T
antigen for cell proliferation. J Invest Dermatol. 134:1479–1481.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bichakjian CK, Olencki T, Alam M, Andersen
JS, Berg D, Bowen GM, Cheney RT, Daniels GA, Glass LF, Grekin RC,
et al: Merkel cell carcinoma, version 1.2014. J Natl Compr Canc
Netw. 12:410–424. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chawla-Sarkar M, Lindner DJ, Liu YF,
Williams BR, Sen GC, Silverman RH and Borden EC: Apoptosis and
interferons: Role of interferon-stimulated genes as mediators of
apoptosis. Apoptosis. 8:237–249. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Willmes C, Adam C, Alb M, Völkert L,
Houben R, Becker JC and Schrama D: Type I and II IFNs inhibit
Merkel cell carcinoma via modulation of the Merkel cell
polyomavirus T antigens. Cancer Res. 72:2120–2128. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Olieman AF, Liénard D, Eggermont AM, Kroon
BB, Lejeune FJ, Hoekstra HJ and Koops HS: Hyperthermic isolated
limb perfusion with tumor necrosis factor alpha, interferon gamma,
and melphalan for locally advanced nonmelanoma skin tumors of the
extremities: A multicenter study. Arch Surg. 134:303–307. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rosenberg SA, Restifo NP, Yang JC, Morgan
RA and Dudley ME: Adoptive cell transfer: A clinical path to
effective cancer immunotherapy. Nat Rev Cancer. 8:299–308. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Viral Oncoprotein Targeted Autologous T
Cell Therapy for Merkel Cell CarcinomaClinicaltrials.gov. Bethesda
(MD): National Library of Medicine; 2014
|
|
34
|
https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000043-78/DE
|
|
35
|
Hoos A: Development of immuno-oncology
drugs-from CTLA4 to PD1 to the next generations. Nat Rev Drug
Discov. 15:235–247. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shah MH, Lorigan P, O'Brien ME, Fossella
FV, Moore KN, Bhatia S, Kirby M and Woll PJ: Phase I study of
IMGN901, a CD56-targeting antibody-drug conjugate, in patients with
CD56-positive solid tumors. Invest New Drugs. 34:290–299. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim J and McNiff JM: Nuclear expression of
survivin portends a poor prognosis in Merkel cell carcinoma. Mod
Pathol. 21:764–769. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dresang LR, Guastafierro A, Arora R,
Normolle D, Chang Y and Moore PS: Response of Merkel cell
polyomavirus-positive merkel cell carcinoma xenografts to a
survivin inhibitor. PLoS One. 8:e805432013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shah MH, Varker KA, Collamore M, Zwiebel
JA, Coit D, Kelsen D and Chung KY: G3139 (Genasense) in patients
with advanced merkel cell carcinoma. Am J Clin Oncol. 32:174–179.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Verhaegen ME, Mangelberger D, Weick JW,
Vozheiko TD, Harms PW, Nash KT, Quintana E, Baciu P, Johnson TM,
Bichakjian CK and Dlugosz AA: Merkel cell carcinoma dependence on
bcl-2 family members for survival. J Invest Dermatol.
134:2241–2250. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zeng Q, Gomez BP, Viscidi RP, Peng S, He
L, Ma B, Wu TC and Hung CF: Development of a DNA vaccine targeting
Merkel cell polyomavirus. Vaccine. 30:1322–1329. 2012. View Article : Google Scholar : PubMed/NCBI
|
